Wednesday, April 2, 2025
spot_img

Form 8.5 (EPT/RI) – Advanced Medical Solutions Group plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:         Investec Bank plc
(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offeree
Advanced Medical Solutions Group plc
(c)        Name of the party to the offer with which exempt principal trader is connected: Investec is Financial Adviser, NOMAD and Corporate Broker to Advanced Medical Solutions Group plc
(d)        Date dealing undertaken: 31st March 2025
(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?
        If it is a cash offer or possible cash offer, state “N/A”
N/A

2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchases/ sales

Total number of securities Highest price per unit paid/received Lowest price per unit paid/received

Ordinary shares

Purchases

442,549

238 232

Ordinary shares

Sales

438,474

236.85

232

(b)        Cash-settled derivative transactions

Class of relevant security Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
N/A N/A N/A N/A N/A

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
e.g. American, European etc.
Expiry date Option money paid/ received per unit
N/A N/A N/A N/A N/A N/A N/A N/A

(ii)        Exercise

Class of relevant security Product description
e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit
N/A N/A N/A N/A N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing
e.g. subscription, conversion
Details Price per unit (if applicable)
N/A N/A N/A N/A

3.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)        the voting rights of any relevant securities under any option; or
(ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure: 01st April 2025
Contact name: Abhishek Gawde
Telephone number: +91 9923757332

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Powered by SlickText.com

Hot this week

WENDEL: Shareholders’ Meeting set for May 15, 2025

Shareholders’ Meeting set for May 15, 2025 Wendel...

Heimar hf.: Termination of Market Making Agreement with Landsbankinn hf.

Heimar hf. ("Heimar") has terminated its market making agreement...

Roche provides update on Phase III OCREVUS high dose study in people with relapsing multiple sclerosis

MUSETTE trial was designed to determine whether a higher...

Convening of the Annual General Meeting of Euronext N.V.

Convening of the Annual General Meeting of Euronext N.V....

Euronext publishes its detailed dividend payment schedule for 2025

Euronext publishes its detailed dividend payment schedule for 2025        ...

Topics

WENDEL: Shareholders’ Meeting set for May 15, 2025

Shareholders’ Meeting set for May 15, 2025 Wendel...

Heimar hf.: Termination of Market Making Agreement with Landsbankinn hf.

Heimar hf. ("Heimar") has terminated its market making agreement...

Convening of the Annual General Meeting of Euronext N.V.

Convening of the Annual General Meeting of Euronext N.V....

Euronext publishes its detailed dividend payment schedule for 2025

Euronext publishes its detailed dividend payment schedule for 2025        ...

Banijay Group N.V.: Convening of the annual general meeting

Paris – 2 April 2025 Convening of the...

Nextensa welcomes Proximus at Tour & Taxis and acquires Proximus towers in Brussels

PRESS RELEASE                                                                              REGULATED INFORMATION INSIDE...
spot_img

Related Articles

Popular Categories

spot_img